Multifocal BRAF(V600E)-Mutated Melanoma in situ on the Foot

被引:0
|
作者
Iwama, Eimei [1 ]
Fujimura, Taku [1 ]
Kusakari, Yoshiyuki [1 ]
Haga, Takahiro [1 ]
Aiba, Setsuya [1 ]
机构
[1] Tohoku Univ, Grad Sch Med, Dept Dermatol, Sendai, Miyagi, Japan
来源
CASE REPORTS IN DERMATOLOGY | 2015年 / 7卷 / 03期
关键词
Malignant melanoma in situ; BRAF(V600E) mutation; PD-L1;
D O I
10.1159/000441601
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Melanoma is an aggressive skin cancer that originates from melanocytes, and about one half of melanoma cases possess a BRAF mutation. Together with PD-L1 expression, the BRAF(V600E) mutation is one of the optimal therapeutic targets for the treatment of melanoma. In this report, we describe a case of multifocal melanoma in situ on the foot, which carried the p.V600E mutation in the BRAF gene. Interestingly, the spotted melanoma lesion is demarcated by normal skin, and in all spotted pigmented lesions, there were no signs of dermal invasion of melanoma cells or spontaneous regression. Our case presented atypical clinical features, which might correlate with the local mutations of BRAF gene and the immunological expression of PD-L1. (C) 2015 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:322 / 327
页数:6
相关论文
共 50 条
  • [31] V600E BRAF Mutation in Vulvovaginal Melanoma Is Rare: A Study of Anti-Human BRAF V600E Monoclonal Antibody in 24 Cases
    Ramineni, M.
    Malpica, A.
    Luthra, R.
    Deavers, M. T.
    Euscher, E. D.
    LABORATORY INVESTIGATION, 2013, 93 : 293A - 293A
  • [32] Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
    Nelson, Blessie Elizabeth
    Reddy, Neha K.
    Huse, Jason T.
    Amini, Behrang
    Nardo, Mirella
    Gouda, Mohamed
    Weathers, Shiao-Pei
    Subbiah, Vivek
    NPJ PRECISION ONCOLOGY, 2023, 7 (01)
  • [33] Histological transformation to gliosarcoma with combined BRAF/MEK inhibition in BRAF V600E mutated glioblastoma
    Blessie Elizabeth Nelson
    Neha K. Reddy
    Jason T. Huse
    Behrang Amini
    Mirella Nardo
    Mohamed Gouda
    Shiao-Pei Weathers
    Vivek Subbiah
    npj Precision Oncology, 7
  • [34] Two patients diagnosed with coexisting hematologic and oncologic BRAF V600E mutated malignancies. Which entity is really carrying the BRAF (V600E) mutation?
    Schlick, K.
    Troch, M.
    Placher-Sorko, G.
    Faber, V
    Neureiter, D.
    Greil, R.
    Hopfinger, G.
    ONKOLOGIE, 2013, 36 : 168 - 169
  • [35] Utility of BRAF V600E Mutation-Specific Immunohistochemistry in Detecting BRAF V600E-Mutated Gastrointestinal Stromal Tumors
    Patil, Deepa T.
    Ma, Shuang
    Konishi, Mai
    Carver, Paula D.
    Pukay, Marina
    Beadling, Carol
    Corless, Christopher L.
    Rubin, Brian P.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 (05) : 782 - 789
  • [36] Genomic complexity and BRAF/MEK-dependence in V600E BRAF mutant melanoma
    Xing, Feng
    Persaud, Yogindra
    Pratilas, Christine
    Janakiraman, Manickam
    She, Qing-Bai
    Liu, Cailian
    Dolgalev, Igor
    Heguy, Adriana
    Wolchok, Jedd
    Cobrinik, David
    Houghton, Alan
    Taylor, Barry
    Rosen, Neal
    Solit, David
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [37] Dabrafénib and tramétinib in BRAF V600E mutated pediatric gliomas
    Giorgis, Olivia
    Doz, Francois
    BULLETIN DU CANCER, 2024, 111 (05) : 429 - 430
  • [38] Highly Concordant Results Between Immunohistochemistry and Molecular Testing of Mutated V600E BRAF in Primary and Metastatic Melanoma
    Manfredi, Laure
    Meyer, Nicolas
    Tournier, Emilie
    Grand, David
    Uro-Coste, Emmanuelle
    Rochaix, Philippe
    Brousset, Pierre
    Lamant, Laurence
    ACTA DERMATO-VENEREOLOGICA, 2016, 96 (05) : 630 - 634
  • [39] Targeted therapy with vemurafenib in BRAF(V600E)-mutated anaplastic thyroid cancer
    Lang, Matthias
    Longerich, Thomas
    Anamaterou, Chrysanthi
    THYROID RESEARCH, 2023, 16 (01)
  • [40] Canadian Consensus for Treatment of BRAF V600E Mutated Pediatric and AYA Gliomas
    Erker, Craig
    Vanan, Magimairajan Issai
    Larouche, Valerie
    Nobre, Liana
    Cacciotti, Chantel
    Vairy, Stephanie
    Zelcer, Shayna
    Fleming, Adam
    Bouffet, Eric
    Jabado, Nada
    Legault, Genevieve
    Renzi, Samuele
    McKeown, Tara
    Crooks, Bruce
    Thacker, Nirav
    Ramaswamy, Vijay
    Coltin, Hallie
    Lafay-Cousin, Lucie
    Cheng, Sylvia
    Hukin, Juliette
    Climans, Seth Andrew
    Lim-Fat, Mary Jane
    McKillop, Sarah
    Lapointe, Sarah
    Alves, Melanie
    Bennett, Julie
    Tabori, Uri
    Perreault, Sebastien
    CURRENT ONCOLOGY, 2024, 31 (07) : 4022 - 4029